Invention Grant
- Patent Title: Combinations comprising siponimod and laquinimod for the treatment of multiple sclerosis
-
Application No.: US15517280Application Date: 2015-10-14
-
Publication No.: US10537566B2Publication Date: 2020-01-21
- Inventor: Paul Alfred Smith
- Applicant: Paul Alfred Smith
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Novartis AG
- Agent Laura Madden
- International Application: PCT/IB2015/057870 WO 20151014
- International Announcement: WO2016/059571 WO 20160421
- Main IPC: A61K31/4704
- IPC: A61K31/4704 ; A61K31/397
Abstract:
The present invention relates to combinations and pharmaceutical compositions comprising siponimod and laquinimod, and the use of said combinations and/or compositions for the treatment of multiple sclerosis, particularly secondary progressive multiple sclerosis.
Public/Granted literature
- US20170304289A1 COMBINATIONS COMPRISING SIPONIMOD AND LAQUINIMOD FOR THE TREATMENT OF MULTIPLE SCLEROSIS Public/Granted day:2017-10-26
Information query
IPC分类:
